Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Works of C. Beauchemin being referenced
Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma
2019
Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| C. Beauchemin | 89 | 25 | 163 | 101 | 90 | 42 | 510 | |
| Omer Gendelman | 11 | 98 | 107 | 75 | 47 | 49 | 509 | |
| Cosetta Bianchi | 29 | 26 | 43 | 27 | 76 | 32 | 563 | |
| Montserrat García | 19 | 25 | 60 | 48 | 76 | 30 | 472 | |
| Rachel E. Sobel | 29 | 125 | 62 | 20 | 24 | 32 | 523 | |
| Zeina G. Khodr | 39 | 14 | 155 | 10 | 64 | 22 | 544 | |
| Laura-Aline Martínez-Martínez | 14 | 55 | 242 | 122 | 28 | 23 | 532 | |
| Patrick Gagnon‐Sanschagrin | 53 | 16 | 127 | 42 | 42 | 41 | 567 | |
| Miriam Kimel | 49 | 142 | 93 | 27 | 53 | 32 | 542 | |
| Dominique Lejeune | 33 | 53 | 31 | 31 | 52 | 62 | 527 | |
| Sachiko Tanaka‐Mizuno | 11 | 7 | 55 | 23 | 61 | 54 | 473 |
All Works
Login with ORCID to disown or claim papers
Loading papers...